Skin of Color Seminar Series

Home | Contact Us June 2^nd, 2012
Las Vegas, NV April 14^th, 2012
Crowne Plaza Times Square
New York, NY

This brochure is available for download upon completion of this form.

First Name:
Last Name:
Title (Ex: MD, RN):
Company:
Medical Specialty:
Address 1:
Address 2:
City:
State/Province:
Postal Code:
Country:
Phone:
Fax:
Email:
	YES! I would be interested in receiving future conference information by email.
	YES! I would be interested in receiving future conference information by fax.

Site Partners

Accreditation Statement:
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of Louisville and SanovaWorks. The University of Louisville is accredited by the ACCME to provide continuing education for physicians.

Designation Statement:
The University of Louisville Continuing Health Sciences Education office designates this educational activity for a maximum of 13.25 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Target Audience
This CME activity is designed for practicing dermatologists, dermatology residents and fellows, and allied health professionals with an interest in improving skin of color patient outcomes in Dermatology.

Learning Objectives
Upon completion of this CME activity, participants will be able to:

Identify the top dermatological issues for patients with skin of color.
Distinguish the prominent differences between skin of color and Caucasian skin and how each reacts to acne, melasma, rosacea, and laser treatments.
Formulate informed treatment regimens for patients with skin of color.
Classify skin of color on at least one established scale.
Contrast treatment regimens for Caucasian and skin of color patients.
Determine the efficacy and safety of laser use in patients with skin types of IV to VI, with fewer risks of epidermal adverse events.
Assess appropriate laser settings for treatments of skin of color patients.
Explain how fillers and neurotoxins must be utilized with specific patient populations in mind.
Discuss the importance of sun protection specialized treatment regimens for skin of color patients.
Indicate the importance of patient compliance and adherence to sunscreen use.
Distinguish the differences between skin of color and Caucasian skin in regards to skin cancer incidence and clinical presentation.
Recognize best treatment options for skin rejuvenation and skin aging for patients with pigmented skin.
Detect and manage common skin conditions in skin of color pediatric patients.